---
category: news
title: "Harvard spinout Nabla Bio nabs $11M for AI-driven antibody design"
excerpt: "Nabla Bio is developing an artificial intelligence-powered drug design platform to engineer next-generation antibody therapeutics and counts George Church, so-called father of synthetic biology, as its academic co-founder."
publishedDateTime: 2021-12-07T13:34:00Z
originalUrl: "https://www.fiercebiotech.com/medtech/ai-driven-antibody-designer-nabla-bio-raises-11m-seed-funding"
webUrl: "https://www.fiercebiotech.com/medtech/ai-driven-antibody-designer-nabla-bio-raises-11m-seed-funding"
type: article
quality: 39
heat: 39
published: false

provider:
  name: FierceBiotech
  domain: fiercebiotech.com

topics:
  - AI in Healthcare
  - AI

images:
  - url: "https://qtxasset.com/fiercebiotech/1638891430/GettyImages-1226985345.jpg/GettyImages-1226985345.jpg?VersionId=HxAuKkW0py1n4T65umGGjVjp.inRRXgq"
    width: 800
    height: 450
    isCached: true

secured: "5sZuAbeKoTf1mUG6B6tDeTXtoOA9QwDf+89yKPx3cCHgwTuEOmK97Vwso0/tydZuLa8d51kukkzYDB3R2pCWJ7C2B4n7TYBF7JPJ6tgDs3HQLipy7M3Zp0HlfTUaKp//0KOc+cLo9kaxvsqlf1XCWrtTKjLURqtZoJFBEXoT/CaJgBEQ4i8xR9IaA22R7eehyr51dE8CUwY/gKFRNGXNdJll5iL4O2nK1yms+8jYNpECuBYoWXzepPNN+uyqEEg7/2xeh53cbtWT+YbvI+bgsIZ6mney5Hu6xXd03fIVdYiw26oSnUTSyZX7jUo4jizN3K9D9DtoA/geHc6JjlRjSqoGWDuobP6jGlq/PQCmmz0=;OggZaL8JU0yquMwZ5wBh5w=="
---

